Stay updated on Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now presents the ClinicalTrials.gov record for a completed study of pembrolizumab with chemoradiation for locally advanced laryngeal cancer. It includes the study design, eligibility criteria, treatment arms, measured outcomes, and study documents.
    Difference
    44%
    Check dated 2026-11-08T13:55:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:14:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:11:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T15:22:38.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T14:48:12.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. Previously visible study documents and navigation are no longer viewable, indicating the content has been restricted.
    Difference
    17%
    Check dated 2026-09-20T20:21:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.